Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs ROA 2011-2025 | PRPH

Current and historical return on assets (ROA) values for ProPhase Labs (PRPH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
ProPhase Labs ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-06-30 $-0.04B $0.04B -66.40%
2025-03-31 $-0.04B $0.05B -57.53%
2024-12-31 $-0.05B $0.06B -62.54%
2024-09-30 $-0.03B $0.09B -30.43%
2024-06-30 $-0.03B $0.09B -28.26%
2024-03-31 $-0.02B $0.09B -25.21%
2023-12-31 $-0.02B $0.09B -17.30%
2023-09-30 $-0.01B $0.09B -9.84%
2023-06-30 $0.00B $0.09B -3.23%
2023-03-31 $0.01B $0.10B 7.39%
2022-12-31 $0.02B $0.09B 18.75%
2022-09-30 $0.03B $0.10B 32.21%
2022-06-30 $0.03B $0.10B 28.89%
2022-03-31 $0.02B $0.10B 21.30%
2021-12-31 $0.01B $0.09B 8.67%
2021-09-30 $-0.01B $0.07B -7.55%
2021-06-30 $0.00B $0.08B -1.86%
2021-03-31 $0.00B $0.09B 0.00%
2020-12-31 $0.00B $0.03B -10.26%
2020-09-30 $0.00B $0.02B -6.78%
2020-06-30 $0.00B $0.01B -7.69%
2020-03-31 $0.00B $0.01B -14.29%
2019-12-31 $0.00B $0.01B -13.11%
2019-09-30 $0.00B $0.02B -11.43%
2019-06-30 $0.00B $0.02B -16.00%
2019-03-31 $0.00B $0.02B -9.88%
2018-12-31 $0.00B $0.02B -4.08%
2018-09-30 $0.00B $0.02B -3.60%
2018-06-30 $0.00B $0.02B -3.10%
2018-03-31 $0.00B $0.03B -7.64%
2017-12-31 $0.04B $0.03B 90.61%
2017-09-30 $0.04B $0.04B 100.00%
2017-06-30 $0.04B $0.05B 122.39%
2017-03-31 $0.04B $0.06B 175.00%
2016-12-31 $0.00B $0.01B -23.53%
2016-09-30 $0.00B $0.01B -22.64%
2016-06-30 $0.00B $0.01B -14.81%
2016-03-31 $0.00B $0.01B -22.22%
2015-12-31 $0.00B $0.02B -21.43%
2015-09-30 $0.00B $0.01B -21.05%
2015-06-30 $-0.01B $0.01B -45.90%
2015-03-31 $-0.01B $0.02B -46.38%
2014-12-31 $-0.01B $0.02B -45.07%
2014-09-30 $-0.01B $0.02B -33.33%
2014-06-30 $0.00B $0.02B -11.27%
2014-03-31 $0.00B $0.02B -6.06%
2013-12-31 $0.00B $0.02B 0.00%
2013-09-30 $0.00B $0.02B -6.15%
2013-06-30 $0.00B $0.02B -6.15%
2013-03-31 $0.00B $0.02B -6.15%
2012-12-31 $0.00B $0.02B -11.94%
2012-09-30 $0.00B $0.02B -23.19%
2012-06-30 $0.00B $0.02B -22.22%
2012-03-31 $0.00B $0.02B -16.00%
2011-12-31 $0.00B $0.02B -15.58%
2011-09-30 $0.00B $0.02B -10.00%
2011-06-30 $0.00B $0.02B -9.76%
2011-03-31 $0.00B $0.02B -14.29%
2010-12-31 $0.00B $0.02B -13.95%
2010-09-30 $0.00B $0.02B 0.00%
2010-06-30 $0.00B $0.02B 0.00%
2010-03-31 $0.00B $0.02B -15.58%
2009-12-31 $0.00B $0.02B -20.78%
2009-09-30 $-0.01B $0.02B -40.00%
2009-06-30 $-0.01B $0.02B -35.96%
2009-03-31 $-0.01B $0.02B -24.24%
2008-12-31 $-0.01B $0.02B -22.64%
2008-09-30 $0.00B $0.03B -6.90%
2008-06-30 $0.00B $0.03B -6.67%
2008-03-31 $0.00B $0.03B -9.76%
2007-12-31 $0.00B $0.03B -9.52%
2007-09-30 $0.00B $0.03B -12.60%
2007-06-30 $0.00B $0.03B -12.60%
2007-03-31 $0.00B $0.03B -9.45%
2006-12-31 $0.00B $0.04B -6.30%
2006-09-30 $0.00B $0.03B -3.13%
2006-06-30 $0.00B $0.03B 3.10%
2006-03-31 $0.00B $0.03B 6.35%
2005-12-31 $0.00B $0.04B 9.68%
2005-09-30 $0.00B $0.03B 10.00%
2005-06-30 $0.00B $0.03B 0.00%
2005-03-31 $0.00B $0.03B 3.74%
2004-12-31 $0.00B $0.03B 0.00%
2004-09-30 $0.00B $0.02B 4.17%
2004-06-30 $0.00B $0.02B 4.17%
2004-03-31 $0.00B $0.03B 4.17%
2003-12-31 $0.00B $0.03B 4.26%
2003-09-30 $-0.01B $0.02B -21.51%
2003-06-30 $-0.01B $0.02B -25.26%
2003-03-31 $-0.01B $0.02B -24.49%
2002-12-31 $-0.01B $0.03B -28.87%
2002-09-30 $0.00B $0.03B -12.37%
2002-06-30 $0.00B $0.03B -8.33%
2002-03-31 $0.00B $0.02B -8.51%
2001-12-31 $0.00B $0.03B 0.00%
2001-09-30 $0.00B $0.02B -4.12%
2001-06-30 $0.00B $0.02B -4.08%
2001-03-31 $0.00B $0.02B -8.08%
2000-12-31 $-0.01B $0.03B -23.53%
2000-09-30 $-0.01B $0.03B -25.69%
2000-06-30 $-0.01B $0.02B -24.35%
2000-03-31 $-0.01B $0.03B -19.67%
1999-12-31 $0.00B $0.03B -11.76%
1999-09-30 $0.00B $0.03B 0.00%
1999-06-30 $0.00B $0.03B 7.02%
1999-03-31 $0.00B $0.04B 8.56%
1998-12-31 $0.01B $0.05B 14.51%
1998-09-30 $0.01B $0.05B 26.80%
1998-06-30 $0.01B $0.05B 32.18%
1998-03-31 $0.02B $0.05B 41.38%
1997-12-31 $0.02B $0.05B 65.57%
1997-09-30 $0.01B $0.03B 65.82%
1997-06-30 $0.01B $0.02B 64.00%
1997-03-31 $0.01B $0.02B 87.50%
1996-12-31 $0.00B $0.01B 50.00%
1996-09-30 $0.00B $0.00B -400.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.012B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $74.015B 28.11
Zoetis (ZTS) United States $52.689B 18.86
Takeda Pharmaceutical (TAK) Japan $43.402B 8.86
Daiichi Sankyo, - (DSNKY) Japan $41.941B 20.89
BeOne Medicines - (ONC) Switzerland $36.448B 193.23
Sandoz Group AG (SDZNY) Switzerland $29.586B 0.00
United Therapeutics (UTHR) United States $19.548B 17.20
Merck (MKKGY) Germany $16.433B 10.69
Neurocrine Biosciences (NBIX) United States $15.434B 37.03
Shionogi (SGIOY) Japan $14.445B 13.27
Summit Therapeutics (SMMT) United States $14.228B 0.00
Ionis Pharmaceuticals (IONS) United States $12.002B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.096B 0.00
Orion OYJ (ORINY) Finland $8.793B 25.12
Eisai (ESAIY) $8.166B 0.00
Corcept Therapeutics (CORT) United States $7.685B 83.02
Stevanato Group S.p.A (STVN) Italy $7.392B 41.37
Grifols, S.A (GRFS) Spain $5.748B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.549B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.173B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.096B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.662B 17.40
Centessa Pharmaceuticals (CNTA) United Kingdom $3.058B 0.00
Hypermarcas (HYPMY) Brazil $2.899B 21.80
Dyne Therapeutics (DYN) United States $2.600B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.580B 8.23
Soleno Therapeutics (SLNO) United States $2.339B 0.00
Ocular Therapeutix (OCUL) United States $2.265B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.839B 21.80
Avadel Pharmaceuticals (AVDL) Ireland $1.817B 0.00
Guardian Pharmacy Services (GRDN) United States $1.804B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.373B 0.00
Collegium Pharmaceutical (COLL) United States $1.281B 6.36
Harrow (HROW) United States $1.274B 0.00
Xeris Biopharma Holdings (XERS) United States $1.245B 0.00
Oruka Therapeutics (ORKA) United States $1.175B 0.00
Evotec AG (EVO) Germany $1.174B 0.00
Relay Therapeutics (RLAY) United States $1.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.111B 0.00
Enliven Therapeutics (ELVN) United States $1.084B 0.00
Nektar Therapeutics (NKTR) United States $1.048B 0.00
Xencor (XNCR) United States $1.000B 0.00
Cronos Group (CRON) Canada $0.946B 0.00
ProKidney (PROK) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.810B 0.00
Theravance Biopharma (TBPH) United States $0.749B 61.96
Aquestive Therapeutics (AQST) United States $0.748B 0.00
Savara (SVRA) United States $0.688B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.656B 5.85
Elite Pharmaceuticals (ELTP) United States $0.645B 0.00
Bioventus (BVS) United States $0.618B 12.68
Siga Technologies (SIGA) United States $0.585B 8.01
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Akebia Therapeutics (AKBA) United States $0.533B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.510B 0.00
Esperion Therapeutics (ESPR) United States $0.504B 0.00
Organogenesis (ORGO) United States $0.493B 0.00
Lexeo Therapeutics (LXEO) United States $0.455B 0.00
Galectin Therapeutics (GALT) United States $0.360B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.78
Altimmune (ALT) United States $0.348B 0.00
Lyell Immunopharma (LYEL) United States $0.344B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.333B 51.25
Korro Bio (KRRO) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Larimar Therapeutics (LRMR) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.252B 0.00
Aclaris Therapeutics (ACRS) United States $0.246B 0.00
Achieve Life Sciences (ACHV) Canada $0.242B 0.00
Nature's Sunshine Products (NATR) United States $0.242B 14.30
Journey Medical (DERM) United States $0.242B 0.00
AleAnna (ANNA) United States $0.219B 0.00
Avalo Therapeutics (AVTX) United States $0.203B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
MediWound (MDWD) Israel $0.200B 0.00
OmniAb (OABI) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.166B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.153B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Inhibikase Therapeutics (IKT) United States $0.111B 0.00
Surrozen (SRZN) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Context Therapeutics (CNTX) United States $0.098B 0.00
Champions Oncology (CSBR) United States $0.095B 34.40
Vivani Medical (VANI) United States $0.093B 0.00
Avita Medical (RCEL) United States $0.091B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Relmada Therapeutics (RLMD) United States $0.087B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.079B 0.00
Prelude Therapeutics (PRLD) United States $0.076B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Nutriband (NTRB) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Talphera (TLPH) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Plus Therapeutics (PSTV) United States $0.051B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 27.38
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Heatwurx (PCSA) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Lipocine (LPCN) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.26
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00